Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Swinnen, J. V.
Right arrow Articles by Ascoli, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Swinnen, J. V.
Right arrow Articles by Ascoli, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 266, Issue 22, 14383-14389, Aug, 1991

Attenuation of cAMP-mediated responses in MA-10 Leydig tumor cells by genetic manipulation of a cAMP-phosphodiesterase [published erratum appears in J Biol Chem 1992 Jan 25;267(3):2114]

JV Swinnen, B D'Souza, M Conti and M Ascoli
Department of Pediatrics, University of North Carolina, Chapel Hill 27599.

In order to assess the effect of increased cAMP degradation on the responsiveness on an endocrine cell, we have obtained stable transfectants of MA-10 Leydig tumor cells that overexpress a mammalian cAMP-phosphodiesterase. Two novel cell lines, designated MA-10(P+8) and MA-10(P+29), that express high levels of the transfected enzyme were characterized. Although the basal levels of cAMP in the mutant cell lines are comparable to those of the wild-type cells, the increase in cAMP accumulation elicited by human choriogonadotropin (hCG) is severely blunted. Further studies with MA-10(P+29) show that the ability of hCG to stimulate adenylyl cyclase activity is normal. The failure of MA-10(P+29) cells to accumulate cAMP in response to hCG can be correlated with a similar reduction in hCG-stimulated steroidogenesis. On the other hand, the maximal steroidogenic response of MA-10(P+29) cells to dibutyryl cAMP, a cAMP analogue that is fairly resistant to phosphodiesterase degradation, is normal. We also show that the ability of these cells to respond to hCG with increased cAMP accumulation and steroid synthesis can be restored with a specific phosphodiesterase inhibitor. These results demonstrate that overexpression of a cAMP-phosphodiesterase in MA-10 cells limits the levels of cAMP attained under hCG stimulation and supresses the steroidogenic response of these cells to hCG. Since gonadotropins increase the cAMP-phosphodiesterase activity in their target cells, these findings also provide evidence that this regulation plays a major role in the modulation of cell responsiveness. Last, these new cell lines should be valuable in the study of the actions of cAMP because they express a conditional and reversible cAMP-resistant phenotype.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
V. Vasta, M. Shimizu-Albergine, and J. A. Beavo
Modulation of Leydig cell function by cyclic nucleotide phosphodiesterase 8A
PNAS, December 26, 2006; 103(52): 19925 - 19930.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
M. A. Giembycz and R. Newton
Beyond the dogma: novel {beta}2-adrenoceptor signalling in the airways.
Eur. Respir. J., June 1, 2006; 27(6): 1286 - 1306.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Ammoun, L. Johansson, M. E. Ekholm, T. Holmqvist, A. S. Danis, L. Korhonen, O. A. Sergeeva, H. L. Haas, K. E. O. Akerman, and J. P. Kukkonen
OX1 Orexin Receptors Activate Extracellular Signal-Regulated Kinase in Chinese Hamster Ovary Cells via Multiple Mechanisms: The Role of Ca2+ Influx in OX1 Receptor Signaling
Mol. Endocrinol., January 1, 2006; 20(1): 80 - 99.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
R S Bhaskaran and M Ascoli
The post-endocytotic fate of the gonadotropin receptors is an important determinant of the desensitization of gonadotropin responses
J. Mol. Endocrinol., April 1, 2005; 34(2): 447 - 457.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
T. Hirakawa and M. Ascoli
The Lutropin/Choriogonadotropin Receptor-Induced Phosphorylation of the Extracellular Signal-Regulated Kinases in Leydig Cells Is Mediated by a Protein Kinase A-Dependent Activation of Ras
Mol. Endocrinol., November 1, 2003; 17(11): 2189 - 2200.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
H. Yoshida, L. Beltran-Parrazal, P. Butler, M. Conti, A. C. Charles, and R. I. Weiner
Lowering Cyclic Adenosine-3',5'-Monophosphate (cAMP) Levels by Expression of a cAMP-Specific Phosphodiesterase Decreases Intrinsic Pulsatile Gonadotropin-Releasing Hormone Secretion from GT1 Cells
Mol. Endocrinol., October 1, 2003; 17(10): 1982 - 1990.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Paruthiyil, M. E. Majdoubi, M. Conti, and R. I. Weiner
Phosphodiesterase expression targeted to gonadotropin-releasing hormone neurons inhibits luteinizing hormone pulses in transgenic rats
PNAS, December 24, 2002; 99(26): 17191 - 17196.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Hirakawa, C. Galet, and M. Ascoli
MA-10 Cells Transfected with the Human Lutropin/Choriogonadotropin Receptor (hLHR): A Novel Experimental Paradigm to Study the Functional Properties of the hLHR
Endocrinology, March 1, 2002; 143(3): 1026 - 1035.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Mehats, G. Tanguy, E. Dallot, D. Cabrol, F. Ferre, and M.-J. Leroy
Is Up-Regulation of Phosphodiesterase 4 Activity by PGE2 Involved in the Desensitization of {beta}-Mimetics in Late Pregnancy Human Myometrium?
J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5358 - 5365.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Oki, S.-I. Takahashi, H. Hidaka, and M. Conti
Short Term Feedback Regulation of cAMP in FRTL-5 Thyroid Cells. ROLE OF PDE4D3 PHOSPHODIESTERASE ACTIVATION
J. Biol. Chem., April 6, 2000; 275(15): 10831 - 10837.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S.-L. C. Jin, F. J. Richard, W.-P. Kuo, A. J. D'Ercole, and M. Conti
Impaired growth and fertility of cAMP-specific phosphodiesterase PDE4D-deficient mice
PNAS, October 12, 1999; 96(21): 11998 - 12003.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-L. C. Jin, T. Bushnik, L. Lan, and M. Conti
Subcellular Localization of Rolipram-sensitive, cAMP-specific Phosphodiesterases. DIFFERENTIAL TARGETING AND ACTIVATION OF THE SPLICING VARIANTS DERIVED FROM THE PDE4D GENE
J. Biol. Chem., July 31, 1998; 273(31): 19672 - 19678.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. B. Bolger, I. McPhee, and M. D. Houslay
Alternative Splicing of cAMP-specific Phosphodiesterase mRNA Transcripts
J. Biol. Chem., January 12, 1996; 271(2): 1065 - 1071.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Grange, C. Sette, M. Cuomo, M. Conti, M. Lagarde, A.-F. Prigent, and G. Nemoz
The cAMP-specific Phosphodiesterase PDE4D3 Is Regulated by Phosphatidic Acid Binding. CONSEQUENCES FOR cAMP SIGNALING PATHWAY AND CHARACTERIZATION OF A PHOSPHATIDIC ACID BINDING SITE
J. Biol. Chem., October 20, 2000; 275(43): 33379 - 33387.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1991 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement